AlzChem Group AG
ALZCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,712 | $1,269 | $1,032 | $576 |
| - Cash | $93 | $64 | $91 | $62 |
| + Debt | $0 | $48 | $0 | $53 |
| Enterprise Value | $1,619 | $1,252 | $941 | $567 |
| Revenue | $161 | $143 | $145 | $139 |
| % Growth | 12.7% | -1.2% | 4.1% | – |
| Gross Profit | $52 | $101 | $92 | $95 |
| % Margin | 32.2% | 70.9% | 63.5% | 68.7% |
| EBITDA | $36 | $30 | $28 | $29 |
| % Margin | 22.3% | 20.8% | 19.4% | 21% |
| Net Income | $19 | $16 | $15 | $15 |
| % Margin | 11.9% | 11.1% | 10.1% | 10.9% |
| EPS Diluted | 1.89 | 1.57 | 1.44 | 1.49 |
| % Growth | 20.4% | 9% | -3.4% | – |
| Operating Cash Flow | – | $22 | $50 | $30 |
| Capital Expenditures | – | -$27 | $0 | $0 |
| Free Cash Flow | – | -$6 | $50 | $30 |